<?xml version="1.0" encoding="UTF-8"?>
<p>2) Vaccination. How closely the influenza antigens included in the annual vaccine match the viruses that circulate in the coming season determines the vaccine’s efficacy. For 2019–2020, influenza vaccine effectiveness was 45% in the United States—a level comparable to years in which close vaccine antigen-circulating strain matching occurred (
 <xref rid="R4" ref-type="bibr">
  <italic>4</italic>
 </xref>). Influenza vaccine coverage for the previous season was only 45% among adults in the United States, despite the recommendation for universal vaccination (
 <xref rid="R5" ref-type="bibr">
  <italic>5</italic>
 </xref>). Thus, as we await SARS-CoV-2 vaccine trials, plans to mitigate the overall burden of respiratory disease should include efforts to increase rates of vaccination against influenza, particularly among older adults who have increased susceptibility to both influenza and COVID-19.
</p>
